Michela Lai
Research Subjects
Michela Lai has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Giovanni Pellacani
Department of Clinical Sciences, Sapienza University of Rome, 00185 Rome, Italy
13 shared publications - Riccardo Pampena
Private Practice Formia Italy
13 shared publications - Caterina Longo
Department of Dermatology University of Modena and Reggio Emilia Modena Italy
12 shared publications Caterina Longo
Department of Dermatology, University of Modena and Reggio Emilia , Modena
7 shared publications- Simonetta Piana
Pathology Unit, Arcispedale Santa Maria Nuova, Azienda USL‐IRCCS Reggio Emilia Italy
6 shared publications Margherita Raucci
Skin Cancer Center, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia , Reggio Emilia
5 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
Tumour-Vascular Interface in melanomas with Breslow thickness ≥0.8 mm: A Confocal Microscopy Study
Background: Due to the limited laser penetration depth, reflectance confocal microscopy (RCM) application in the study of thick cutaneous lesions has been limited so far. Objectives: To describe clinical, histopathological, dermoscopic and RCM features of cutaneous melanomas with Breslow thickness ≥0.8 mm, to identify possible differences among different histological subtypes, and describe new RCM features of these tumours, with a focus on their potential impact on prognosis. Methods: We conducted a retrospective, single-centre, study. We assessed the presence of a new RCM feature named “tumour-vascular interface” (TVI) defined as the presence of vessels adjacent to melanocytic structures. The included cases were classified according to melanoma histotype and the presence of TVI. Results: A total of 197 melanomas were included and comprehensive description of their clinicopathological, dermoscopic and RCM features was provided. Most cases were superficial spreading melanomas (72.6%) and nodular melanomas (16.2%). The mean Breslow thickness was 2.3 mm (SD ±2.4; range 0.8-25). TVI was identified in 83 cases (42.1%). TVI+ cases were more frequently amelanotic/hypomelanotic (p = 0.011) and ulcerated (p= 0.093) and exhibited a higher mitotic rate (p=0.002). No significant differences in mortality rate or disease progression were observed between TVI+ and TVI- melanomas though TVI+ cases showed a trend toward higher nodal relapse rates (p=0.068). Conclusions: This study provides an in-depth analysis of clinicopathological, dermoscopic and RCM features of invasive cutaneous melanomas, suggesting a potential new application of RCM in the study of melanoma vascularization and its possible correlation with clinical behaviour
- 14 October 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
Open AccessTumour-Vascular Interface in melanomas with Breslow thickness ≥0.8 mm: A Confocal Microscopy Study
Background: Due to the limited laser penetration depth, reflectance confocal microscopy (RCM) application in the study of thick cutaneous lesions has been limited so far. Objectives: To describe clinical, histopathological, dermoscopic and RCM features of cutaneous melanomas with Breslow thickness ≥0.8 mm, to identify possible differences among different histological subtypes, and describe new RCM features of these tumours, with a focus on their potential impact on prognosis. Methods: We conducted a retrospective, single-centre, study. We assessed the presence of a new RCM feature named “tumour-vascular interface” (TVI) defined as the presence of vessels adjacent to melanocytic structures. The included cases were classified according to melanoma histotype and the presence of TVI. Results: A total of 197 melanomas were included and comprehensive description of their clinicopathological, dermoscopic and RCM features was provided. Most cases were superficial spreading melanomas (72.6%) and nodular melanomas (16.2%). The mean Breslow thickness was 2.3 mm (SD ±2.4; range 0.8-25). TVI was identified in 83 cases (42.1%). TVI+ cases were more frequently amelanotic/hypomelanotic (p = 0.011) and ulcerated (p= 0.093) and exhibited a higher mitotic rate (p=0.002). No significant differences in mortality rate or disease progression were observed between TVI+ and TVI- melanomas though TVI+ cases showed a trend toward higher nodal relapse rates (p=0.068). Conclusions: This study provides an in-depth analysis of clinicopathological, dermoscopic and RCM features of invasive cutaneous melanomas, suggesting a potential new application of RCM in the study of melanoma vascularization and its possible correlation with clinical behaviour
- 25 April 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (5) , 720-721
Pregnancy‐associated melanoma: New evidence and unsolved issues
- 25 April 2026
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (5) , 720-721
Pregnancy‐associated melanoma: New evidence and unsolved issues
- 23 January 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (7) , 1385-1394
Characterization of different clinical presentations of Merkel cell carcinomas and their potential prognostic implications
Background: Recent studies have analysed the impact of Merkel cell polyomavirus (MCPyV) on the clinical features and prognosis of patients with Merkel cell carcinoma (MCC). However, there are currently no available data on specific morphological clinical differences of MCC according to MCPyV-positive (MCPyV+) and -negative (MCPyV−) status and any possible prognostic implications of the different clinical presentations. Objectives: To describe the clinicopathological characteristics of patients with MCC and the prevalence of MCPyV infection in an Italian cohort of patients and to define possible differences in clinicopathological and prognostic features among MCPyV+ and MCPyV− MCCs. Methods: A retrospective, multicentre cohort study was conducted in two Italian tertiary referral centres. MCPyV presence was detected by immunohistochemistry and real-time polymerase chain reaction (RT-PCR) with two different primer sets, amplifying the viral protein (VP1) or large T antigen (LT) viral regions (VP1-PCR and LT-PCR, respectively). Clinicopathological features were compared between MCPyV+ and MCPyV− tumours and between red exophytic nodules and subcutaneous cyst-like MCCs. Results: Of the 62 MCCs that were included, 43 (69%) presented as red exophytic nodules and 12 (19%) with a subcutaneous cyst-like appearance; MCPyV was detected in 25 cases (40%) by IHC, 35 (56%) by VP1-PCR and 49 (79%) by LT-PCR. No correlation was found between clinical morphology and viral status. Mortality rate was higher for MCPyV− cases (77%) than for MCPyV+ (23%) (P = 0.239) and higher for red nodules (70%) than for cyst-like lesions (59%) (P = 0.005). By multivariable analysis, age at diagnosis, Ki67 proliferation index and treatment with surgery/radiotherapy remained the only factors significantly affecting overall survival. Conclusions: This study highlights the potential impact of clinical morphology of MCCs on prognosis. Subcutaneous cyst-like morphology may provide a survival benefit to the patients, regardless of MCPyV status.
- 23 January 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (7) , 1385-1394
Characterization of different clinical presentations of Merkel cell carcinomas and their potential prognostic implications
Background: Recent studies have analysed the impact of Merkel cell polyomavirus (MCPyV) on the clinical features and prognosis of patients with Merkel cell carcinoma (MCC). However, there are currently no available data on specific morphological clinical differences of MCC according to MCPyV-positive (MCPyV+) and -negative (MCPyV−) status and any possible prognostic implications of the different clinical presentations. Objectives: To describe the clinicopathological characteristics of patients with MCC and the prevalence of MCPyV infection in an Italian cohort of patients and to define possible differences in clinicopathological and prognostic features among MCPyV+ and MCPyV− MCCs. Methods: A retrospective, multicentre cohort study was conducted in two Italian tertiary referral centres. MCPyV presence was detected by immunohistochemistry and real-time polymerase chain reaction (RT-PCR) with two different primer sets, amplifying the viral protein (VP1) or large T antigen (LT) viral regions (VP1-PCR and LT-PCR, respectively). Clinicopathological features were compared between MCPyV+ and MCPyV− tumours and between red exophytic nodules and subcutaneous cyst-like MCCs. Results: Of the 62 MCCs that were included, 43 (69%) presented as red exophytic nodules and 12 (19%) with a subcutaneous cyst-like appearance; MCPyV was detected in 25 cases (40%) by IHC, 35 (56%) by VP1-PCR and 49 (79%) by LT-PCR. No correlation was found between clinical morphology and viral status. Mortality rate was higher for MCPyV− cases (77%) than for MCPyV+ (23%) (P = 0.239) and higher for red nodules (70%) than for cyst-like lesions (59%) (P = 0.005). By multivariable analysis, age at diagnosis, Ki67 proliferation index and treatment with surgery/radiotherapy remained the only factors significantly affecting overall survival. Conclusions: This study highlights the potential impact of clinical morphology of MCCs on prognosis. Subcutaneous cyst-like morphology may provide a survival benefit to the patients, regardless of MCPyV status.
- Open Access
Molecular and Histopathological Characterization of Metastatic Cutaneous Squamous Cell Carcinomas: A Case–Control Study
Background: A subset of patients affected by cutaneous squamous cell carcinoma (cSCC) can exhibit locally invasive or metastatic tumors. Different staging classification systems are currently in use for cSCC. However, precise patient risk stratification has yet to be reached in clinical practice. The study aims to identify specific histological and molecular parameters characterizing metastatic cSCC. Methods: Patients affected by metastatic and non-metastatic cSCC (controls) were included in the present study and matched for clinical and histological characteristics. Skin samples from primary tumors were revised for several histological parameters and also underwent gene expression profiling with a commercially available panel testing 770 different genes. Results: In total, 48 subjects were enrolled in the study (24 cases, 24 controls); 67 genes were found to be differentially expressed between metastatic and non-metastatic cSCC. Most such genes were involved in immune regulation, skin integrity, angiogenesis, cell migration and proliferation. Conclusion: The combination of histological and molecular profiles of cSCCs allows the identification of features specific to metastatic cSCC, with potential implications for more precise patient risk stratification.
Open AccessMolecular and Histopathological Characterization of Metastatic Cutaneous Squamous Cell Carcinomas: A Case–Control Study
Background: A subset of patients affected by cutaneous squamous cell carcinoma (cSCC) can exhibit locally invasive or metastatic tumors. Different staging classification systems are currently in use for cSCC. However, precise patient risk stratification has yet to be reached in clinical practice. The study aims to identify specific histological and molecular parameters characterizing metastatic cSCC. Methods: Patients affected by metastatic and non-metastatic cSCC (controls) were included in the present study and matched for clinical and histological characteristics. Skin samples from primary tumors were revised for several histological parameters and also underwent gene expression profiling with a commercially available panel testing 770 different genes. Results: In total, 48 subjects were enrolled in the study (24 cases, 24 controls); 67 genes were found to be differentially expressed between metastatic and non-metastatic cSCC. Most such genes were involved in immune regulation, skin integrity, angiogenesis, cell migration and proliferation. Conclusion: The combination of histological and molecular profiles of cSCCs allows the identification of features specific to metastatic cSCC, with potential implications for more precise patient risk stratification.
- 15 February 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 63 (7) , 890-892
A rapidly growing nodule on the face during pregnancy
It is well known that adnexal skin tumors can simulate other cutaneous neoplasia and that various types of benign and malignant skin tumors can develop or modify during pregnancy. Here, we report a case of trichoblastoma mimicking a keratoacanthoma arising in a nevus sebaceous during pregnancy. Given its unique clinical and dermoscopic features, this case highlights the pivotal role of clinicopathological correlation in the diagnosis of adnexal tumors with an atypical clinical presentation.
- 15 February 2024
- Published by Wiley in International Journal of Dermatology
- Vol. 63 (7) , 890-892
A rapidly growing nodule on the face during pregnancy
It is well known that adnexal skin tumors can simulate other cutaneous neoplasia and that various types of benign and malignant skin tumors can develop or modify during pregnancy. Here, we report a case of trichoblastoma mimicking a keratoacanthoma arising in a nevus sebaceous during pregnancy. Given its unique clinical and dermoscopic features, this case highlights the pivotal role of clinicopathological correlation in the diagnosis of adnexal tumors with an atypical clinical presentation.
- 21 June 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (10) , E1253-E1255
Dermoscopic features of trichoepithelioma: A multicentre observational case–control study conducted by the International Dermoscopy Society
- 21 June 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (10) , E1253-E1255
Dermoscopic features of trichoepithelioma: A multicentre observational case–control study conducted by the International Dermoscopy Society
- Open Access
- 2 June 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (9) , 1758-1776
Melanoma in children: A systematic review and individual patient meta‐analysis
The current evidence on paediatric melanoma is heterogeneous, especially regarding the prognosis of different histological subtypes. We sought to systematically review the evidence on paediatric melanoma, highlighting the major sources of heterogeneity and focusing on available data on single patients. A systematic search was performed from 1948 to 25 January 2021. Only studies reporting at least one case of cutaneous melanoma in patients aged ≤18 years were included. Unknown primary and uncertain malignant melanomas were excluded. Three couples of authors independently performed title/abstract screening and two different authors reviewed all the relevant full texts. The selected articles were manually cross‐checked for overlapping data for qualitative synthesis. Subsequently data on single patients were extracted to perform a patient‐level meta‐analysis. PROSPERO registration number: CRD42021233248. The main outcomes were melanoma‐specific survival (MSS) and progression‐free survival (PFS) outcomes. Separate analyses were done of cases with complete information on histologic subtype, focusing on superficial spreading (SSM), nodular (NM) and spitzoid melanomas, as well as of those classified asde‐novo(DNM) and acquired or congenital nevus‐associated melanomas (NAM). The qualitative synthesis covered 266 studies; however, data on single patients were available from 213 studies including 1002 patients. Among histologic subtypes, NM had a lower MSS than both SSM and spitzoid melanoma, and a lower PFS than SSM. Spitzoid melanoma had a significantly higher progression risk than SSM and trended toward lower mortality. Focusing on nevus‐associated status, DNM demonstrated better MSS after progression than congenital NAM, and no differences were highlighted in PFS. Our findings describe the existence of different biological patterns in paediatric melanoma. Specifically, spitzoid melanomas demonstrated intermediate behaviour between SSM and NM and showed a high risk of nodal progression but low mortality. This raises the question of whether spitzoid lesions are being over‐diagnosed as melanoma in childhood.
- 2 June 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (9) , 1758-1776
Open AccessMelanoma in children: A systematic review and individual patient meta‐analysis
The current evidence on paediatric melanoma is heterogeneous, especially regarding the prognosis of different histological subtypes. We sought to systematically review the evidence on paediatric melanoma, highlighting the major sources of heterogeneity and focusing on available data on single patients. A systematic search was performed from 1948 to 25 January 2021. Only studies reporting at least one case of cutaneous melanoma in patients aged ≤18 years were included. Unknown primary and uncertain malignant melanomas were excluded. Three couples of authors independently performed title/abstract screening and two different authors reviewed all the relevant full texts. The selected articles were manually cross‐checked for overlapping data for qualitative synthesis. Subsequently data on single patients were extracted to perform a patient‐level meta‐analysis. PROSPERO registration number: CRD42021233248. The main outcomes were melanoma‐specific survival (MSS) and progression‐free survival (PFS) outcomes. Separate analyses were done of cases with complete information on histologic subtype, focusing on superficial spreading (SSM), nodular (NM) and spitzoid melanomas, as well as of those classified asde‐novo(DNM) and acquired or congenital nevus‐associated melanomas (NAM). The qualitative synthesis covered 266 studies; however, data on single patients were available from 213 studies including 1002 patients. Among histologic subtypes, NM had a lower MSS than both SSM and spitzoid melanoma, and a lower PFS than SSM. Spitzoid melanoma had a significantly higher progression risk than SSM and trended toward lower mortality. Focusing on nevus‐associated status, DNM demonstrated better MSS after progression than congenital NAM, and no differences were highlighted in PFS. Our findings describe the existence of different biological patterns in paediatric melanoma. Specifically, spitzoid melanomas demonstrated intermediate behaviour between SSM and NM and showed a high risk of nodal progression but low mortality. This raises the question of whether spitzoid lesions are being over‐diagnosed as melanoma in childhood.
- Open Access
- 31 January 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (1) , e2023057
Clinical Review of Mucosal Melanoma: The 11-Year Experience of a Referral Center
Introduction: Mucosal melanoma is a rare neoplasm. Late diagnosis is caused by occult anatomic sites and scarcity of symptoms. Novel biological therapies have now become available. Demographic, therapeutical and survival records on mucosal melanoma are scarce. Objectives: To provide an 11-year retrospective clinical review of real-world data on mucosal melanomas managed in a tertiary referral center in Italy. Methods: We included patients with histopathological mucosal melanoma diagnosis from January 2011 to December 2021. Data were collected until last known follow up or death. Survival analysis was performed. Results: Among 33 patients, we found 9 sinonasal, 13 anorectal and 11 urogenital mucosal melanomass (median age 82, females 66.7%). Eighteen cases (54.5%) presented with metastasis (p<0.05). In the urogenital subgroup, only 4 patients (36.4%) had metastasis at diagnosis, all in regional lymph nodes. Sinonasal melanomas were surgically managed with a debulking procedure (44.4%); every case of anorectal and urogenital melanomas underwent radical surgery (30.8% and 45.5%). Fifteen patients were treated with biological therapy (p<0.05). Radiation therapy was used in all melanomas of the sinonasal region (p<0.05). Overall survival was longer for urogenital melanomas (26 months). Univariate analysis showed an increased hazard ratio for death in patients with metastasis. A negative prognostic value of metastatic status was reported by the multivariate model, while administration of first-line immunotherapy demonstrated a protective role. Conclusions: At diagnosis, the absence of metastatic disease is the most relevant factor that influences the survival of mucosal melanomas. Moreover, the use of immunotherapy might prolong the survival of metastatic mucosal melanoma patients.
- 31 January 2023
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 13 (1) , e2023057
Open AccessClinical Review of Mucosal Melanoma: The 11-Year Experience of a Referral Center
Introduction: Mucosal melanoma is a rare neoplasm. Late diagnosis is caused by occult anatomic sites and scarcity of symptoms. Novel biological therapies have now become available. Demographic, therapeutical and survival records on mucosal melanoma are scarce. Objectives: To provide an 11-year retrospective clinical review of real-world data on mucosal melanomas managed in a tertiary referral center in Italy. Methods: We included patients with histopathological mucosal melanoma diagnosis from January 2011 to December 2021. Data were collected until last known follow up or death. Survival analysis was performed. Results: Among 33 patients, we found 9 sinonasal, 13 anorectal and 11 urogenital mucosal melanomass (median age 82, females 66.7%). Eighteen cases (54.5%) presented with metastasis (p<0.05). In the urogenital subgroup, only 4 patients (36.4%) had metastasis at diagnosis, all in regional lymph nodes. Sinonasal melanomas were surgically managed with a debulking procedure (44.4%); every case of anorectal and urogenital melanomas underwent radical surgery (30.8% and 45.5%). Fifteen patients were treated with biological therapy (p<0.05). Radiation therapy was used in all melanomas of the sinonasal region (p<0.05). Overall survival was longer for urogenital melanomas (26 months). Univariate analysis showed an increased hazard ratio for death in patients with metastasis. A negative prognostic value of metastatic status was reported by the multivariate model, while administration of first-line immunotherapy demonstrated a protective role. Conclusions: At diagnosis, the absence of metastatic disease is the most relevant factor that influences the survival of mucosal melanomas. Moreover, the use of immunotherapy might prolong the survival of metastatic mucosal melanoma patients.
- 21 January 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (6) , E718-E719
Blue skin: Intravascular melanoma metastasis detected by means of dermoscopy
- 21 January 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (6) , E718-E719
Blue skin: Intravascular melanoma metastasis detected by means of dermoscopy
- 26 June 2022
- Published by Wiley in Experimental Dermatology
- Vol. 31 (10) , 1554-1562
Characteristics and management of skin cancers in very elderly patients: A real‐world challenge for clinicians
The increase life expectancy led to an expected increase in skin cancer incidence in older patients. Their treatment can require a complex decision‐making process. Limited data are available on characteristics, management and outcome of skin tumours in nonagenarian and centenarian patients. The aim of our study was to describe epidemiology, clinical‐pathological features and treatment strategies of skin cancers in a cohort of patients aged ≧95 years. A total of 116 patients ≧95 years of age presented for the evaluation of 225 skin lesions (mean of 1.94 lesions per patient). The mean age was 97.4 years, 57.8% were women. Most patients had an ECOG score of 3 (49.3%) or 4 (32%). Lesions were mainly located on the head and neck area (74.2%), upper (7.1%) and lower (6,2%) limbs. The majority of patients presented with non‐melanoma skin cancers (183/225; 81.3%), 25/225 (11.1%) had actinic keratosis, 5 (2.2%) melanoma and 2 (0.9%) atypical fibroxanthoma. Forty‐eight lesions (21.3%) were treated with surgery, 58 (25.8%) with radiotherapy. The management of 73 lesion (32.4%) was discussed at the multidisciplinary tumour board meeting. One patient died for the progression of a squamous cell carcinoma; 74 patients died for causes unrelated to skin tumours, 36 are still alive after a mean follow‐up of 27.27 months. This cohort study confirms that age is not per se a contraindication for treatment of skin cancers in elderly patients. Our results support the importance of a patient‐centred care approach that should take into consideration patient's preferences, comorbidities, compliance and possible adverse events.
- 26 June 2022
- Published by Wiley in Experimental Dermatology
- Vol. 31 (10) , 1554-1562
Characteristics and management of skin cancers in very elderly patients: A real‐world challenge for clinicians
The increase life expectancy led to an expected increase in skin cancer incidence in older patients. Their treatment can require a complex decision‐making process. Limited data are available on characteristics, management and outcome of skin tumours in nonagenarian and centenarian patients. The aim of our study was to describe epidemiology, clinical‐pathological features and treatment strategies of skin cancers in a cohort of patients aged ≧95 years. A total of 116 patients ≧95 years of age presented for the evaluation of 225 skin lesions (mean of 1.94 lesions per patient). The mean age was 97.4 years, 57.8% were women. Most patients had an ECOG score of 3 (49.3%) or 4 (32%). Lesions were mainly located on the head and neck area (74.2%), upper (7.1%) and lower (6,2%) limbs. The majority of patients presented with non‐melanoma skin cancers (183/225; 81.3%), 25/225 (11.1%) had actinic keratosis, 5 (2.2%) melanoma and 2 (0.9%) atypical fibroxanthoma. Forty‐eight lesions (21.3%) were treated with surgery, 58 (25.8%) with radiotherapy. The management of 73 lesion (32.4%) was discussed at the multidisciplinary tumour board meeting. One patient died for the progression of a squamous cell carcinoma; 74 patients died for causes unrelated to skin tumours, 36 are still alive after a mean follow‐up of 27.27 months. This cohort study confirms that age is not per se a contraindication for treatment of skin cancers in elderly patients. Our results support the importance of a patient‐centred care approach that should take into consideration patient's preferences, comorbidities, compliance and possible adverse events.